Narmac,  I agree DM and management are horrible and are the only reason why the Sp is at .15 cents

Truth be told if DM had more than the pea for a brain he might just realize he doesn't have the business experience, large biotech peer respect(most likely) ie part of the club do take Apabetalone to the next level after failing with BETONMACE. He would be better off financially  either sellling RVX off even at a discounted valuation  via a CVR deal or  milestone buyout to a BP  or  trying  to find a seasoned suitable experienced  BIOTECH CEO who can get the financing without major dilution to get the  BETONMACE2 trial moving along.  I think his $500K salary plus $100K Zenith per year is to lucrative to give up....  Even though doing the above might get a larger  SP and market valuation 

Lets see what plays out in the next few months but the market is not antipating very much at .15 cents